Stay updated with breaking news from Nilogen Oncosystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Former VP of Research and Operations steps into new roleTAMPA, Fla.--(BUSINESS WIRE)--Nilogen Oncosystems, a privately-held biotechnology company dedicated to increasing efficiency and reducing risk in the oncology drug development process, has announced the appointment of its Vice President of Research and Operatio...
Scailyte closes Series A funding with a CHF 6 million investment to develop strategic partnerships Scailyte closes Series A funding with a CHF 6 million investment to develop strategic partnerships in immuno-oncology BASEL, Switzerland - September 21, 2022...
/PRNewswire/ -- Nilogen Oncosystems today announced that its clinical observational study TUMORIN (NCT05332925) has commenced enrolment. Patients with...
The partners will integrate Nilogen's 3D tumor modeling platform and Scailyte's platform for detecting predictive molecular signatures.
TAMPA, Fla. and BASEL, Switzerland, July 12, 2022 /PRNewswire/ -- Nilogen Oncosystems, a leading Oncology drug development Company; and Scailyte, ...